Abstract
The importance of this topic is underscored by the dismal prognosis of pancreatic adenocarcinoma (PC), with an overall 5-year survival of <5% [ 1 x [1] Warshaw, A. and Fernandez-del Castillo, C. Pancreatic carcinoma. N Engl J Med. 1992; 326: 455–465 Crossref | PubMed | Scopus (1443) | Google Scholar See all References , 2 x [2] Konner, J. and O'Reilly, E. Pancreatic cancer: epidemiology, genetics and approaches to screening. Oncology. 2002; 16: 1615–1638 PubMed | Google Scholar See all References ]. The best chance of reducing the high mortality of PC is the identification of individuals at risk and the development of screening tests for early diagnosis and treatment [ 3 x [3] Rieder, H. and Bartsch, D. Familial pancreatic cancer. Fam Cancer. 2004; 3: 69–74 Crossref | PubMed | Scopus (28) | Google Scholar See all References ] [3] . The proof that early detection prolongs life is still wanting.

This publication has 21 references indexed in Scilit: